Table 3a.
CCr (mL/min) | Rivaroxaban (ng/mL) | Anti-factor Xa activity (IU/mL) | PT (s) | APTT (s) | |
---|---|---|---|---|---|
Rivaroxaban | |||||
10 mg once daily (6.5 h after) | 47.9 | 783.0 | 3.48 | 23.8 | 38.2 |
Apixaban | |||||
2.5 mg twice daily (5.5 h after) | 49.0 | – | 1.42 | 14.8 | 30.9 |
CCr (mL/min) | Rivaroxaban (ng/mL) | Anti-factor Xa activity (IU/mL) | PT (s) | APTT (s) | |
---|---|---|---|---|---|
Rivaroxaban | |||||
10 mg once daily (6.5 h after) | 47.9 | 783.0 | 3.48 | 23.8 | 38.2 |
Apixaban | |||||
2.5 mg twice daily (5.5 h after) | 49.0 | – | 1.42 | 14.8 | 30.9 |